The vascular access catheters market, valued at approximately USD 3.0 billion by the end of 2022, is expected to experience ...

November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE ... eluting bioresorbable scaffold for treating below-the-knee (BTK) peripheral ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Researchers have developed a groundbreaking coating that could make medical devices safer for millions of patients, reducing the risks associated with blood clots and dangerous bleeding. The new ...

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

"By 2024, the market is projected to reach a staggering US$597.00bn worldwide. Among these markets, Medical Devices are expected to dominate, with a projected market volume of US$508.00bn by 2024.

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET. Company Participants. Matthew Kreps - Investor Relations Jeffrey Soinski - Chief Executiv ...

Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent ...

Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent ...